BillionaireNet
Fan
Dong Fan
Rank #2593
CHINAHealthcareMedical devices

Dong Fan

Net Worth
$1.383B
+0.26% (24h)
Dong Fan is a prominent figure in China's healthcare industry, recognized for his entrepreneurial success in the medical devices sector. With a source of wealth stemming from his company, Jafron Biomedical, Fan has achieved a substantial net worth. His career highlights include founding and leading Jafron Biomedical, a company that went public in 2016 on the Shenzhen Stock Exchange. Fan's contributions to the medical field have been acknowledged through various awards and recognitions, underscoring his impact in the industry. Beyond his business ventures, Fan is also involved in philanthropy, demonstrating a commitment to giving back to society. His career trajectory reflects a blend of business acumen, technological innovation, and a focus on social responsibility.

The Full Dossier

Early Life and Education

Dong Fan graduated from Shanghai University of Finance and Economics and later obtained an MBA from Sun Yat-sen University. This educational foundation provided a strong base for his future endeavors in the business world.

Rise to Success

Dong Fan's career took off with the founding of Jafron Biomedical in 1989. The company, which specializes in medical devices, has grown significantly under his leadership. A key milestone was the company's IPO on the Shenzhen Stock Exchange in August 2016.

Key Business Strategies

Dong Fan holds a 48% stake in Jafron, which indicates his significant role in the company's strategic direction. His leadership has been instrumental in the development and market success of Jafron's medical devices. One notable achievement was the development of the world's first resin hemoadsorption cartridge.

Philanthropy

Dong Fan has been recognized for his philanthropic activities, donating to various causes, particularly through the Zhuhai Jianfan Sunshine Medical Foundation. His contributions showcase his dedication to social responsibility.

Career Timeline

2016

Jafron Biomedical IPO

Took Jafron Biomedical public on the Shenzhen Stock Exchange.

1999

Developed First Resin Hemoadsorption Cartridge

Developed the world's first resin hemoadsorption cartridge.

1989

Founded Jafron Biomedical

Established Jafron Biomedical, a medical device company focused on blood purification and hemoadsorption technology.

Philanthropic Impact

Healthcare$0.9

Zhuhai Jianfan Sunshine Medical Foundation

Donated 6.2 million RMB to the Zhuhai Jianfan Sunshine Medical Foundation (2021).

Wealth Trajectory